Physician profile
Steven Petronijevic
NPI 1790774560
$3,680.19
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,241 · 2020: $649 · 2021: $952 · 2022: $734 · 2023: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $863.86 | 2019-2022 | |
| Glaxosmithkline, LLC. | $550.52 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $543.00 | 2019-2023 | Jardiance |
| Novo Nordisk INC | $201.26 | 2019-2022 | |
| Amgen INC. | $200.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $164.80 | 2019-2021 | |
| Abbott Laboratories | $153.33 | 2022 | |
| Allergan, INC. | $151.34 | 2019-2020 | |
| Pfizer INC. | $147.16 | 2019-2021 | |
| Lilly USA, LLC | $117.98 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $92.48 | 2022 | |
| Merck Sharp & Dohme LLC | $87.06 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $86.51 | 2021-2022 | |
| Mylan Specialty L.P. | $81.80 | 2021-2022 | |
| Boston Scientific Corporation | $71.93 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $64.40 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $37.31 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $22.39 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $22.12 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Petronijevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.